• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 64-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
XXX-0049662-1/1/1 05-Sep-2002 64BCA24 3003502433 Dupont Pharma Italia s.r.l. Italy
 
310-5817201-1/1/1/B 23-Sep-2002 64DCJ99 3003773810 Groupe Parima Inc. Canada
 
582-0791694-1/1/1 13-Sep-2002 64EIY99 3003773904 River Gardens United Kingdom
 
M05-0109565-3/1/1 09-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0324912-6/7/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324912-6/6/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324912-6/5/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324912-6/4/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324912-6/3/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324912-6/2/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324912-6/1/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324791-4/1/1 19-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0324731-0/2/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324731-0/1/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0324724-5/7/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0324724-5/6/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0324724-5/5/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0324724-5/4/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0324724-5/3/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0324724-5/2/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0324724-5/1/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0109652-9/1/1 19-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0109622-2/1/1 19-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0109613-1/1/1 19-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0109609-9/1/1 19-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0109591-9/3/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0109591-9/2/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0109591-9/1/1 19-Sep-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0109586-9/1/1 19-Sep-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0109585-1/1/1 19-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0109573-7/1/1 19-Sep-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0109646-1/1/1 26-Sep-2002 64HDL99 3002952995 Smithkline Beecham Costa Rica S.A. Costa Rica
 
M05-0109670-1/1/1 30-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0109670-1/2/1 30-Sep-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
XXX-0049791-8/1/1 05-Sep-2002 64LAJ67 3002624237 Glaxo Saudi Arabia Ltd. Saudi Arabia
 
XXX-0049791-8/1/2 05-Sep-2002 64LAL67 3002624237 Glaxo Saudi Arabia Ltd. Saudi Arabia
 
112-0967278-2/2/1 27-Sep-2002 64MCK04 1000455820 Pharma Med United Kingdom
 
-
-